Biden's Year 2 Test

Dave Ricks steered the 150-year-old drug giant to a $1 trillion market cap. Can he defeat pharma’s boom-and-bust cycle? By Madison Muller and Brad StoneSee omnystudio.com/listener for privacy information. 

A global group of online sadists is pushing kids to harm their pets, their siblings and themselves. The FBI calls it a new wave of terrorism. By Margi Murphy See omnystudio.com/listener for privacy information. 

Rising inflation, a Covid surge, tensions in Eastern Europe: President Biden is facing challenges nearly everywhere he turns. As voters grow frustrated with higher prices and the ongoing pandemic, Biden tries to balance acknowledging the frustration with insisting his administrat ...  Show more

With the losses piling up, is it time for Joe Biden to hit reset on his Presidency? Plus, the administration announces a new testing plan, but is it too late to stop the surge? And, Donald Trump versus the GOP establishment. On today’s panel: Toluse Olorunnipa of the Washington ...  Show more

President Biden ends his first year in office with the lowest approval ratings of his career. He can also point to some big wins, like a bipartisan infrastructure bill and low unemployment. But can he recover politically as long as Covid still dominates voters’ lives? Plus – Ma ...  Show more

The President heads overseas with his agenda stalled. What could this mean for America and its reputation around the world? Plus: Protesters take to the streets in Sudan to demonstrate against the coup ... How the pandemic has changed our relationship with work and stress.   To l ...  Show more